admin

Covid-19 has caused misery around the globe for more than a year now. There is much evidence in the literature to support the concerns for those with chronic illness and the severe illness that they experience. The American Heart Association (AHA) has reported that for patients in China the most severe cases of illness occurred
0 Comments
This content originally appeared on ForGoodMeasure. Republished with permission. The pairing of chocolate and hazelnuts conjures up creamy, sweet Nutella for most palates. This recipe is about to rearrange your tastebuds. Found in prehistoric China, the hazelnut has shared a long, sacred history in Scandinavia, Scotland and Ireland. It entered the confectionary scene in Italy
0 Comments
Pandemically speaking, we as a country are in a precarious spot. Some states are abandoning their protective regulations while the rates of infections and deaths are not on a straight, downward trajectory. Published reports show a new variant in New York City, one capable of making vaccines less effective. Other reports discuss how obesity is
0 Comments
Joe Wicks may be known to millions now, but he’s had to work tirelessly to get where he is today. So, who could be better than the nation’s favourite PE teacher to share tips on managing your motivation, and watching out for your wellbeing along the way? Say “The Body Coach” to almost anyone, and
0 Comments
PLYMOUTH MEETING, Pa., March 1, 2021 /PRNewswire/ – INOVIO, (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, today announced it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of
0 Comments
Treatment for Presbyopia Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia NORTH CHICAGO, Ill., Feb. 25, 2021 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of
0 Comments
NORTH CHICAGO, Ill., Feb. 24, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Humira (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric patients 5 years of age and older. In clinical trials, Humira induced clinical remission at Week 8 and maintained
0 Comments
Patrons Sari and Peter Melendez enjoy lunch at Katz’s Delicatessen, the famous deli founded in 1888, on the first day of the return to indoor dining for New York City, during the coronavirus disease (COVID-19) pandemic, in New York, February 12, 2021. Brendan McDermid | Reuters Easing mask mandates and reopening restaurants have led to
0 Comments
WASHINGTON — Both public and private health insurance would become less expensive for large numbers of people under the $1.9 trillion COVID relief bill now being debated in the Senate. Provisions Affecting COBRA, ACA Plans The bill contains a number of provisions affecting insurance bought on the Affordable Care Act (ACA) insurance exchanges, as well
0 Comments
I’ve been thinking a lot recently about the hardiness of our spirits. We are all filled with spirit. It is the essence of who we are. Within our spirit we find strength, resilience, character, places of hope and perseverance. The spirit within each of us is a life force that gets us through our challenges.
0 Comments
For many people, taking part in clinical trials or research studies can be a way to help advance science or cures, get free medical tests, and make some cash on the side. The race to find an effective COVID-19 treatment and vaccine increased the number of research studies.  However, a recent report from the FTC,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. On the advice of its independent data monitoring committee (DMC), the RECOVERY trial has stopped recruitment to the colchicine arm for lack of efficacy in patients hospitalized with COVID-19. “The DMC saw no convincing evidence that further recruitment would provide conclusive
0 Comments
A year into the coronavirus pandemic, it’s harder than ever to know what products to trust. The pandemic has given rise to medical and wellness markets filled with misleading claims, rushed solutions, and outright fraudsters hocking counterfeit and inadequate products.  The FDA is working to separate the wheat from the chaff, issuing Emergency Use Authorizations
0 Comments
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A recent decrease in the number of Americans seeking testing for COVID-19 has experts on alert. Accurate and timely testing remains critical for treating and isolating individuals with SARS-CoV-2 infection, they stress. Widespread testing also allows for tracking the spread of the virus and
0 Comments
One of the hallmarks of chronic pain is inflammation, and scientists at the UNC School of Medicine have discovered that anti-inflammatory cells called MRC1+ macrophages are dysfunctional in an animal model of neuropathic pain. Returning these cells to their normal state could offer a route to treating debilitating pain caused by nerve damage or a
0 Comments
Treatment for Narcolepsy Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy DUBLIN, Ireland, March 01, 2021 (GLOBE NEWSWIRE) – Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s New Drug Application (NDA) for FT218,
0 Comments